'
Sharda Cropchem hosted conference call on January 30,2026. In the conference call the company was represented by R V Bubna -CMD, Shailesh Mahendale- CFO and J N Gudhka- Company Secretary.
Key highlights
The company reported a robust performance driven by strong volume growth and an improved product mix, supported by accelerated product registrations. This has helped the company achieve its highest ever PAT for any year.
The global agrochemical market is showing signs of recovery driven by revival in demand complemented by gradual recovery in pricing. Inventories have come to normal levels across distribution channels.
Q3FY2026:
Total revenues grew by 38.7% yoy to Rs 1,289 crores with overall volume growth at 14%. The company has witnessed volume growth in Europe and Latin America which are the key contributors. Volumes from agrochemical segment gr...
Pleaselogin & subscribe to view the full report.
More Reports
-
(05-Feb-2025)
Castrol India
Expects EBITDA margin of 22%-25% for CY25
-
(10-Feb-2023)
Deepak Nitrite
Plans capex of about Rs 1500 crore for FY23 and FY24
-
(09-Feb-2023)
Mayur Uniquoters
Targets revenue of Rs 1000 crore in FY24
-
(31-Jan-2023)
Tega industries
Capex plan is US$ 30-32 million for next three years
|
|
-
Analyst Meet / AGM-Conference Call (17-Feb-2026)
Sharda Cropchem
Revenue growth to be in the range of 15-20% in FY2027
-
Results-Analysis (30-Jan-2026)
Sharda Cropchem
NP up 366% yoy to Rs 145.1 crore in Q3FY2026
-
Analyst Meet / AGM-Conference Call (30-Jan-2026)
Sharda Cropchem
EBITDA margins to be around 18-20% in FY2026 and FY2027
-
Analyst Meet / AGM-Conference Call (01-Nov-2025)
Sharda Cropchem
Expect H2FY26 to be better than H1FY26
|
|